|
DPM3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.418700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.37390000000071E-05 |
| Normal-vs-Stage2 |
9.805000E-01 |
| Normal-vs-Stage3 |
6.761100E-04 |
| Normal-vs-Stage4 |
1.509630E-01 |
| Stage1-vs-Stage2 |
1.378190E-01 |
| Stage1-vs-Stage3 |
9.251000E-01 |
| Stage1-vs-Stage4 |
1.068570E-01 |
| Stage2-vs-Stage3 |
1.561420E-01 |
| Stage2-vs-Stage4 |
4.850200E-01 |
| Stage3-vs-Stage4 |
1.743790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11369999999689E-05 |
| Normal-vs-AfricanAmerican |
1.901770E-01 |
| Normal-vs-Asian |
8.467200E-01 |
| Caucasian-vs-AfricanAmerican |
7.151100E-04 |
| Caucasian-vs-Asian |
2.021800E-01 |
| AfricanAmerican-vs-Asian |
7.388600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.351400E-04 |
| Normal-vs-Female |
1.935690E-02 |
| Male-vs-Female |
2.370200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.153200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.009000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.141300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.506000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.619400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.439800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.126000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.684400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.101000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.423800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.797430E-01 |
| Normal-vs-Grade 2 |
1.581000E-03 |
| Normal-vs-Grade 3 |
1.475300E-03 |
| Normal-vs-Grade 4 |
2.816000E-01 |
| Grade 1-vs-Grade 2 |
6.551600E-01 |
| Grade 1-vs-Grade 3 |
7.884000E-01 |
| Grade 1-vs-Grade 4 |
7.335600E-01 |
| Grade 2-vs-Grade 3 |
8.379600E-01 |
| Grade 2-vs-Grade 4 |
2.073600E-01 |
| Grade 3-vs-Grade 4 |
1.975970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.02659999956911E-07 |
| Normal-vs-ccB subtype |
1.83799999997625E-06 |
| ccA subtype-vs-ccB subtype |
9.036800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.771820E-04 |
| Normal-vs-N1 |
9.541400E-01 |
| N0-vs-N1 |
1.620400E-01 |
|
|
